Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model

Osteoarthritis and Cartilage

Volumn 10, Issue 6, 2002, Pages 471-478

  Choi, J H ^a,a   Kim, D Y ^a   Yoon, J H ^a   Youn, H Y ^a   Yi, J B ^b   Rhee, H I ^b   Ryu, K H ^b   Jung, K ^b   Han, C K ^b   Kwak, W J ^b   Cho, Y B ^b  

^a Seoul National University   (South Korea)

^b SK Chemicals   (South Korea)

Author keywords

Cartilage; Collagenase; Osteoarthritis; Proteoglycan; SKI 306X

Indexed keywords

ANTIINFLAMMATORY AGENT; COLLAGENASE; DEXAMETHASONE; DICLOFENAC; GLYCOSAMINOGLYCAN; HERBACEOUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEOGLYCAN; RECOMBINANT INTERLEUKIN 1ALPHA; ROFECOXIB; SKI 306X; TELAZOL; UNCLASSIFIED DRUG; ZOLETIL 50;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG FORMULATION; IN VITRO STUDY; IN VIVO STUDY; KNEE; MALE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RABBIT; SYNOVIUM; TISSUE CULTURE;

EID: 0036080581     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.2002.0526     Document Type: Article

References (36)

1. Generation and Characterization of aggrecanase
2. Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis
3. The role of cytokines in the development of osteoarthritis
4. Cytokines in osteoarthritis: Mediators on markers of joint destruction
5. Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis?
6. Pathogenesis of osteoarthritis-approaches to specific therapy
7. The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment
8. Glucosamine in the treatment of osteoarthritis
9. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine
10. Preparation of anti-inflammatory herbal drug, SK1306X
11. Subacute toxicity of SK1306X, an anti inflammatory herbal extract, in rats
12. Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: A double-blind placebo controlled study
13. Degradation of proteoglycan in articular cartilage
14. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis
15. The basis and applicability of the dimethylmethylene blue binding assay for sulfated glycosaminoglycans
16. Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis
17. Intra-articular injection of collagenase induces experimental osteoarthritis in mature rabbits
18. The role of COX-2 produced by cartilage in arthritis
19. Dexamethasone inhibits collagen degradation induced by the combination of interleukin-1 and plasminogen in cartilage explant culture
20. The therapeutic effects of NSAID and corticosteroids in osteoarthritis: To be or not to be
21. Preclinical investigations of drug effects in models of osteoarthrosis
22. Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin
23. Rofecoxib
24. Studies on interleukin-1β induced glycosaminoglycan release from rat femoral head cartilage in-vitro
25. Effect of tenidap on cartilage integrity in vitro
26. Nonsteroidal antiin-flammatory drugs: Effects on normal and interleukin 1 treated human articular chondrocyte metabolism in vitro
27. Cyclooxygenase inhibitors augment the production of pro-matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes
28. The biology of osteoarthritis
29. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis
30. Reactive oxygen species induce apoptosis of synoviocytes in vitro, Alpha-tocopherol provides no protection
31. Expression and activity of articular cartilage hyanulronidases
32. Mechanisms involved in cartilage proteoglycan catabolism
33. Metalloproteinase inhibitors and the prevention of connective tissue breakdown
34. Relating matrix metalloproteinase structure to function: Why the hemopexin domain
35. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro